Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | FAAH | O00519 | 8/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | POLA1 | P09884 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.51 |
| ▸ | CASP2 | P42575 | 1/20 | 0.50 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3181828 | 1.00 | RECQL (0.81) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL12960560 | 1.00 | RECQL (0.81) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL21199617 | 1.00 | RECQL (0.81) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL2496886 | 1.00 | RECQL (0.81) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL18796560 | 1.00 | RECQL (0.81) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL12960574 | 1.00 | RECQL (0.81) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL28821416 | 0.98 | RECQL (0.78) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL28821442 | 0.98 | RECQL (0.78) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL28004139 | 0.98 | RECQL (0.78) | RECQLGAAFAAHPOLBPOLA1 | |
| SCHEMBL29289980 | 0.98 | RECQL (0.78) | RECQLGAAFAAHPOLBPOLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9180201-B2 | Method for preparing lipopeptide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-11-10 | — | — | US | disclosed |
| US-20120253012-A1 | METHOD FOR PREPARING LIPOPEPTIDE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-10-04 | — | — | US | disclosed |
| EP-2245157-A1 | METHOD FOR THE EXTRACTION AND PURIFICATION OF NUCLEIC ACIDS ON A MEMBRANE | Millipore Corporation (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009093142-A1 | METHOD FOR THE EXTRACTION AND PURIFICATION OF NUCLEIC ACIDS ON A MEMBRANE | MILLIPORE CORPORATION (US) | 2009-07-30 | — | — | WO | disclosed |
| CN-101023171-A | Formulations and methods for purifying DNA using solid supports | GENTRA SYSTEMS INC (US) | 2007-08-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120253012-A1 | METHOD FOR PREPARING LIPOPEPTIDE COMPOUND | LPXN, VIP, NGLY1 | RECQL 4329/4885GAA 846/4885FAAH 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.